Wimbledon Neurocare Limited - Abbreviated accounts 16.1

Wimbledon Neurocare Limited - Abbreviated accounts 16.1


07487836 1.1.15 31.12.15 31.12.15 Company accounts Private Limited Company FY true false true false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure074878362014-12-31074878362015-12-31074878362015-01-012015-12-31074878362013-12-31074878362014-01-012014-12-31074878362014-12-3107487836ns12:England2015-01-012015-12-3107487836ns14:PoundSterling2015-01-012015-12-3107487836ns7:Director12015-01-012015-12-3107487836ns7:Director22015-01-012015-12-3107487836ns7:OrdinaryShareClass12015-01-012015-12-3107487836ns7:CompanySecretary2015-01-012015-12-3107487836ns7:RegisteredOffice2015-01-012015-12-3107487836ns7:EntityAccountantsOrAuditors2015-01-012015-12-3107487836ns5:PlantMachinery2015-01-012015-12-3107487836ns7:OrdinaryShareClass12015-12-3107487836ns7:OrdinaryShareClass12014-12-31
REGISTERED NUMBER: 07487836 (England and Wales)













WIMBLEDON NEUROCARE LIMITED

ABBREVIATED UNAUDITED ACCOUNTS

FOR THE YEAR ENDED 31ST DECEMBER 2015






WIMBLEDON NEUROCARE LIMITED (REGISTERED NUMBER: 07487836)

CONTENTS OF THE ABBREVIATED ACCOUNTS
FOR THE YEAR ENDED 31ST DECEMBER 2015










Page

Company Information 1

Abbreviated Balance Sheet 2

Notes to the Abbreviated Accounts 4

WIMBLEDON NEUROCARE LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31ST DECEMBER 2015







DIRECTORS: Dr A Y M J Al-Memar
Dr O J F Foster





SECRETARY: P A Stamps





REGISTERED OFFICE: Unit 1 College Fields
16 Prince George Road
London
SW19 2PT





REGISTERED NUMBER: 07487836 (England and Wales)





ACCOUNTANTS: Sinclairs Bartrum Lerner
Chartered Accountants
39A Welbeck Street
London
W1G 8DH

WIMBLEDON NEUROCARE LIMITED (REGISTERED NUMBER: 07487836)

ABBREVIATED BALANCE SHEET
31ST DECEMBER 2015

2015 2014
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 2 225,723 281,047

CURRENT ASSETS
Debtors 3 135,393 258,060
Cash at bank 528,178 310,354
663,571 568,414
CREDITORS
Amounts falling due within one year 66,504 56,472
NET CURRENT ASSETS 597,067 511,942
TOTAL ASSETS LESS CURRENT
LIABILITIES

822,790

792,989

PROVISIONS FOR LIABILITIES 25,755 32,563
NET ASSETS 797,035 760,426

CAPITAL AND RESERVES
Called up share capital 4 508,224 508,224
Share premium 211,120 211,120
Profit and loss account 77,691 41,082
SHAREHOLDERS' FUNDS 797,035 760,426

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31st December 2015.

The members have not required the company to obtain an audit of its financial statements for the year ended 31st December 2015 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies
Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end
of each financial year and of its profit or loss for each financial year in accordance with the requirements of
Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to
financial statements, so far as applicable to the company.

WIMBLEDON NEUROCARE LIMITED (REGISTERED NUMBER: 07487836)

ABBREVIATED BALANCE SHEET - continued
31ST DECEMBER 2015


The abbreviated accounts have been prepared in accordance with the special provisions of Part 15 of the Companies Act 2006 relating to small companies.


The financial statements were approved by the Board of Directors on 23rd September 2016 and were signed on its
behalf by:




Dr A Y M J Al-Memar - Director



Dr O J F Foster - Director


WIMBLEDON NEUROCARE LIMITED (REGISTERED NUMBER: 07487836)

NOTES TO THE ABBREVIATED ACCOUNTS
FOR THE YEAR ENDED 31ST DECEMBER 2015


1. ACCOUNTING POLICIES

Accounting convention
The financial statements have been prepared under the historical cost convention and in accordance with the
Financial Reporting Standard for Smaller Entities (effective January 2015).

Turnover
Turnover comprises revenue recognised by the company in respect of goods and services supplied during the
year, exclusive of Value Added Tax and trade discounts.

Services provided to patients are recognised as turnover according to the date when the treatments are provided.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Plant and machinery etc - 20% straight line on cost and 15% on cost

Deferred tax
Full provision is made for deferred tax assets and liabilities arising from all timing differences between the
recognition of gains and losses in the financial statements and recognition in the tax computation.

A net deferred tax asset is recognised only if it can be regarded as more likely than not that there will be suitable
taxable profits from which the future reversal of the underlying timing differences can be deducted.

Deferred tax assets and liabilities are calculated at the tax rates expected to be effective at the time the timing
differences are expected to reverse.

Deferred tax assets and liabilities are not discounted.

2. TANGIBLE FIXED ASSETS
Total
£   
COST
At 1st January 2015 558,445
Additions 56,340
At 31st December 2015 614,785
DEPRECIATION
At 1st January 2015 277,398
Charge for year 111,664
At 31st December 2015 389,062
NET BOOK VALUE
At 31st December 2015 225,723
At 31st December 2014 281,047

3. DEBTORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR

The aggregate total of debtors falling due after more than one year is £ 7,000 (2014 - £ 7,000 )

WIMBLEDON NEUROCARE LIMITED (REGISTERED NUMBER: 07487836)

NOTES TO THE ABBREVIATED ACCOUNTS - continued
FOR THE YEAR ENDED 31ST DECEMBER 2015


4. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2015 2014
value: £    £   
508,224 Ordinary £1 508,224 508,224

5. CONTROL NOTE

During the current and previous year, the company was under the control of the directors who own together
68% of the issued ordinary share capital.